Evaluation of Zika Singleplex and Multiplex diagnostics for clinical and surveillance use Global DiseasesInnovations & DiagnosticsTechnical Assistance Evaluation of Zika Singleplex and Multiplex diagnostics for clinical and surveillance use GHIG is currently working with the London School of Hygiene and Tropical Medicine (LSHTM) as…
Point-of-Care Day in Latin America Health Systems StrengtheningInnovations & DiagnosticsWorkshops Point-of-Care Day in Latin America GHIG participated in the 2nd annual POC Day in Bogota to support the uptake of…
Evaluation of Grants and Investments in New Diagnostics Advisory/ConsultancyInnovations & DiagnosticsMaternal & Child HealthTechnical Assistance Evaluation of Grants and Investments in New Diagnostics GHIG was asked to serve as an advisor collaborating with Cambridge Economic Policy Associates (CEPA)…
An Investment Case for Lateral Flow Assays (LFAs) for Neglected Tropical Diseases (NTD) Global DiseasesInnovations & DiagnosticsTechnical Assistance An Investment Case for Lateral Flow Assays (LFAs) for Neglected Tropical Diseases (NTD) Ultrasensitive antigen tests are needed for early detection of numerous infectious diseases, and for surveillance…
Industry Innovations in HIV Viral Load (VL) Advisory/ConsultancyHIVInnovations & Diagnostics Industry Innovations in HIV Viral Load (VL) GHIG has worked with numerous industry partners to bring about innovations in HIV viral load…
Accelerating Market Entry and Quality of HIV Point-of-Care (POC) Diagnostics HIVInnovations & DiagnosticsProgram Planning & Implementation Accelerating Market Entry and Quality of HIV Point-of-Care (POC) Diagnostics The Global Health Impact Group (GHIG) provided technical assistance and direction to the 3-year project…